Header
Merken
Natural and Synthetic Phospholipids
For Vaccines and Other Complex Drug Delivery Systems – Part 1
Übersichten
1. Introduction
2. Vaccines
3. Conclusion and Future Perspectives - Part 1
2. Vaccines
3. Conclusion and Future Perspectives - Part 1
Keywords, Phospholipids, Vaccines, Depot injectables, Pulmonary dosage forms
Dr. Richard Wibel1, PD Dr. Peter van Hoogevest2, Dr. Peter Hölig1 · 1Lipoid GmbH, Ludwigshafen am Rhein; 2 · PHARMANOVATION Consulting, Rheinfelden (Baden)
Correspondence:
Dr. Peter Hölig, Lipoid GmbH, Frigenstr. 4, 67065 Ludwigshafen am Rhein, p.hoelig@lipoid.com
 | Dr. Peter Hölig, is a pharmacist by training. In 2022, he obtained his PhD in Pharmaceutical Technology from the University of Innsbruck, Austria. Afterwards, he joined the business development section of Lipoid GmbH where he is responsible for the scientific marketing. is a pharmacist with PhD (biochemistry, Utrecht University, NL) and degree of Privatdozent in pharmacy (University of Basel, |
